Panmira Pharmaceuticals Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
8
- Latest Deal Type
-
M&A
Panmira Pharmaceuticals General Information
Description
Developer of pharmaceutical products for multiple allergic and inflammatory conditions. The company provides small molecule pharmaceutical therapies for inflammatory diseases like asthma, chronic obstructive pulmonary disease and eosinophillic esophagitis.
Contact Information
Website
www.panmira.comCorporate Office
- P.O. Box 81946
- San Diego, CA 92138
- United States
Corporate Office
- P.O. Box 81946
- San Diego, CA 92138
- United States
Panmira Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | Completed | Startup | ||||
| 1. Early Stage VC | 01-Aug-2014 | Completed | Startup |
Panmira Pharmaceuticals Comparisons
Industry
Financing
Details
Panmira Pharmaceuticals Competitors (36)
One of Panmira Pharmaceuticals’s 36 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| PulseSight Therapeutics | Venture Capital-Backed | Paris, France | ||||
| Vertex Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| Evoke Pharma | Formerly VC-backed | Solana Beach, CA | ||||
| Attune Pharmaceuticals | Venture Capital-Backed | New York, NY |
Panmira Pharmaceuticals Patents
Panmira Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2011109679-A3 | Inhibitors of 5-lipoxygenase | Inactive | 05-Mar-2010 | ||
| EP-2521713-A2 | Dp2 antagonist and uses thereof | Inactive | 06-Jan-2010 | ||
| EP-2521713-A4 | Dp2 antagonist and uses thereof | Inactive | 06-Jan-2010 | ||
| CA-2779786-A1 | Novel processes | Inactive | 03-Nov-2009 | ||
| US-20120220779-A1 | Novel processes | Inactive | 03-Nov-2009 | C07D403/14 |
Panmira Pharmaceuticals Signals
Panmira Pharmaceuticals Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Avalon Ventures | Venture Capital | Minority | ||
| Novo Holdings | Venture Capital | Minority | ||
| Prospect Venture Partners | Venture Capital | Minority | ||
| Versant Ventures | Venture Capital | Minority |
Panmira Pharmaceuticals FAQs
-
When was Panmira Pharmaceuticals founded?
Panmira Pharmaceuticals was founded in 2011.
-
Where is Panmira Pharmaceuticals headquartered?
Panmira Pharmaceuticals is headquartered in San Diego, CA.
-
What is the size of Panmira Pharmaceuticals?
Panmira Pharmaceuticals has 8 total employees.
-
What industry is Panmira Pharmaceuticals in?
Panmira Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Panmira Pharmaceuticals a private or public company?
Panmira Pharmaceuticals is a Private company.
-
What is Panmira Pharmaceuticals’s current revenue?
The current revenue for Panmira Pharmaceuticals is .
-
Who are Panmira Pharmaceuticals’s investors?
Avalon Ventures, Novo Holdings, Prospect Venture Partners, and Versant Ventures have invested in Panmira Pharmaceuticals.
-
Who are Panmira Pharmaceuticals’s competitors?
Voyager Therapeutics, PulseSight Therapeutics, Vertex Pharmaceuticals, Evoke Pharma, and Attune Pharmaceuticals are some of the 36 competitors of Panmira Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process